Ocugen, Inc.

Healthcare · Biotechnology · United States

Last price 0.7027 USD (Oct 30, 2026, 4:00 PM EST) · Market cap 238.29M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Ocugen, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies, biologic, and vaccines that improve patients’ health. The company’s pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, currently under Phase 3 trials for the treatment of retinitis pigmentosa and Phase 1/2 trials for the treatment of leber congenital amaurosis; OCU410, a gene therapy under ...